申请人:Millichip Ian
公开号:US20090099216A1
公开(公告)日:2009-04-16
A novel adenine compound represented by the formula (1):
wherein Z represents (un)substituted alkylene, a single bond, etc.; R
1
represents an (un)substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, or heteroaryl group; R
2
represents hydrogen or (un)substituted alkyl; R
3
, R
4
and R
5
each independently represents an (un)substituted alkyl, alkenyl, alkynyl, aryl, or heteroaryl group, provided that R
3
and R
5
may be bonded to each other to form a 3- to 7-membered, saturated carbocycle or heterocycle in cooperation with the adjacent carbon atom; and X represents oxygen, sulfur, SO
2
, NR
6
(R
6
represents hydrogen or alkyl), or a single bond, or a pharmaceutically acceptable salt of the compound. The compound and salt are useful as a medicine.
一种新型腺嘌呤化合物,由公式(1)表示:其中Z代表(未)取代的烷基,单键等;R1代表(未)取代的烷基,烯基,炔基,环烷基,芳基或杂环芳基;R2代表氢或(未)取代的烷基;R3、R4和R5各自独立地表示(未)取代的烷基,烯基,炔基,芳基或杂环芳基,但R3和R5可以与相邻的碳原子合作形成3-至7-环的饱和碳环或杂环;X代表氧,硫,SO2,NR6(R6代表氢或烷基)或单键,或化合物的药学上可接受的盐。该化合物和盐可用作药物。